Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Edita Baltruškevičienė
Format: Artículo científico
Language:fr
Published: Vilniaus Universitetas 2016
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items